Journal of Rare Cardiovascular Diseases

ISSN: 2299-3711 (Print) e-ISSN: 2300-5505 (Online)

Journal of Rare Cardiovascular Diseases

Announcements

Call for Papers

The Journal of Rare Cardiovascular Diseases (JRCD) invites researchers, clinicians, and academicians to submit their high-quality original research papers, reviews, and case studies for publication.

Our journal is dedicated to advancing knowledge and fostering collaboration in the field of rare cardiovascular diseases. We welcome manuscripts that align with the following scope:

Rare diseases of systemic circulation
Rare diseases of pulmonary circulation
Rare diseases of the heart (cardiomyopathies)
Rare congenital cardiovascular diseases
Rare arrhythmogenic disorders
Cardiac tumors and cardiovascular diseases in malignancy
Cardiovascular diseases in pregnancy
Basic science research in cardiovascular health
Quality of life studies related to rare cardiovascular conditions
Note: Submissions on topics outside these areas but relevant to the broader field of rare cardiovascular diseases are also encouraged.

Submission Guidelines:
Researchers are invited to submit their manuscripts directly to the Managing Editor via email at jrcd@jrcd.eu. Please ensure that your submission includes a cover letter, is formatted according to our journal guidelines, and is sent as an email attachment.

We look forward to your valuable contributions to the field of rare cardiovascular diseases. Together, let’s advance understanding and improve care for these challenging conditions.

Transition of Publishing Support for the Journal of Rare Cardiovascular Diseases

We would like to express our heartfelt gratitude to SoftQ sp. z o.o. for their continuous support and dedicated efforts in successfully publishing the Journal of Rare Cardiovascular Diseases over the years. Their contributions have been instrumental in shaping the journal into a trusted platform for sharing valuable research and insights into rare cardiovascular conditions.

As we look toward the future, we are pleased to announce that starting from 2021 onwards, the Journal of Rare Cardiovascular Diseases will be published with the support of MedinLin Soft. This transition marks an exciting new chapter for the journal, enabling us to further enhance our reach, improve publication processes, and continue our mission of disseminating high-quality research in the field of rare cardiovascular diseases.

We extend our sincere thanks to all our readers, authors, and contributors for their continued trust and support. Together, we aim to advance the understanding and management of rare cardiovascular diseases and foster impactful collaboration within the global medical community.

Thank you for being a part of our journey.

Warm regards,
The Editorial Team
Journal of Rare Cardiovascular Diseases

More Announcements…

Vol 4, No 8 (2024)

Table of Contents

.

Atrial Fibrillation Management: The Combined Approach of Left Atrial Appendage Closure and Catheter Ablation                                                                                                                                                                  PDF
John Alex

.

A Comprehensive Framework for Rare Disease Management in Primary Care                                        PDF
Mike George

.

Vol 4, No 7 (2023)

Table of Contents

.

Advances in Right Heart Function Analysis for Prognosis in Heart Failure Patients Undergoing Catheter Ablation                                                                                                                                                                PDF
Thomas Bernhard Elfriede

.

Cardiac Amyloidosis in 2023: Transformative Advances in Diagnosis and Therapy                               PDF
Leo Oscar, George Arthur and k. Amelia

.

Comprehensive Review of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia                   PDF
Pedro Antonio and José Miguel

Vol 4, No 6 (2022)

Table of Contents

.

Enhanced Growth Hormone and IGF-1 Axis Modulation in Chronic Heart Failure: A Multicenter, Double-Blind, Placebo-Controlled Study                                                                                                                       PDF
O. D. Neini

.

Comparative Efficacy and Safety of Radial and Femoral Access for Percutaneous Coronary Intervention (PCI) in the Context of Novel Antithrombotic Regimens and Device Innovations: A 2022 Update        PDF
John Alex and Anton Andrej

.

Adaptive Heart Rate Control in Atrial Fibrillation and Heart Failure: Insights from a Multimodal Monitoring and Intervention Trial                                                                                                                     PDF
Claire Louis, Elise Colette and Juliette Gabriel

.

Vol 4, No 5 (2021)

Table of Contents

.

Association of fibrinogen and D‑dimer levels with severity of acute coronary syndromes                     PDF
Prabhu M M, Madireddi J M, Shetty R R, Stanley W W

.


A case of Loeffler endocarditis with extensive right ventricular thrombosis                                               PDF
Oryshchyn N, Ivaniv Y